Based on the aggregated intelligence of 130,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Chinese medical-device maker Mindray Medical (NYSE:MR) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Mindray's business and see what CAPS investors are saying about the stock right now.

Mindray facts

Headquarters (founded)

Shenzhen, China (1999)

Market Cap

$2.46 billion

Industry

Health-care equipment

Trailing-12-Month Revenue

$547.5 million

Management

Founder/Co-CEO Xiting Li
Chairman/Co-CEO Xu Hang

Return on Equity (average, last three years)

24.8%

Competitors

Abbott Labs (NYSE:ABT)
Siemens (NYSE:SI)
General Electric (NYSE:GE)

CAPS members bullish on MR also bullish on

Apple (NASDAQ:AAPL)
Suntech Power (NYSE:STP)

CAPS members bearish on MR also bearish on

General Motors (NYSE:GM)

Sources: Capital IQ (a division of Standard & Poor's), and Motley Fool CAPS.

Over on CAPS, 1,533 of the 1,554 members who have rated Mindray -- some 99% -- believe the stock will outperform the S&P 500 going forward. These bulls include All-Star auron77, who is ranked in the top 1% of our community, and Northville.

In late March, auron77 wrote that "there is massive growth potential for this company within China's market." Our CAPS All-Star concludes: "With China being a country where health care is expanding and new technologies are making way to more and more hospitals this company has a large, ever expanding market to serve."

In a pitch from one month earlier, Northville also helps our community keep their minds on Mindray:

Think about this for a second. [Mindray] sells medical devices into China, an underdeveloped country with the world's largest population which has just announced a plan to improve their healthcare system. Even if this was [Mindray's] only market (which it isn't), at a PE in line with the industry average the possibilities for leaving the market in the dust over the next few years are enormous. WOW.

What do you think about Mindray Medical, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 130,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Mindray Medical and Suntech are Motley Fool Rule Breakers recommendations. Apple is a Stock Advisor selection. The Fool owns shares of Mindray. The Fool's disclosure policy always gets a perfect score.